Latest Biotechnology, Pharmaceutical and Healthcare News from BioPharma-Reporter

21:41 EDT 24th March 2018 | BioPortfolio

Here are the most relevant search results for "BioPharma-Reporter" found in our extensive news archives from over 250 global news sources.

More Information about BioPharma-Reporter on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about BioPharma-Reporter for you to read. Along with our medical data and news we also list BioPharma-Reporter Clinical Trials, which are updated daily. BioPortfolio also has a large database of BioPharma-Reporter Companies for you to search.

Showing News Articles 1–25 of 324 from BioPharma-Reporter

Friday 23rd March 2018

Tillots Pharma licenses CHO cell line tech from Lonza and BioWa

Lonza and BioWaâs POTELLIGENT CHOK1SV technology will be licensed by Tillots Pharma to develop its antibody pipeline.

Abzena strikes deal to access cell lines

Abzena has gained access to a major mammalian cell line depository it says will cut license negotiations for its customers.

Nohla signs WuXi AppTec to make cell therapies for bone marrow function

Nohla Therapeutics has selected WuXi AppTec Advanced Therapies to make its lead candidate, indicated to treat patients with hematologic malignances.

Wednesday 21st March 2018

MaSTherCell to make TCR candidates for Zelluna

Zelluna Immunotherapy has selected MaSTherCell as manufacturing partner for its T-cell receptor (TCR)-based immunotherapies.

WuXi Biologics adds 4,000L bioreactors at fully single-use site

The CMO says adding the single-use offering from ABEC will make the newly opened biomanufacturing site in China comparable to stainless steel for commercial mAb production.

A top three biopharma by 2025? ‘Late to the game’ Sanofi plays catch-up

The traditionally small molecule firm was âlate to the biologics gameâ, but Sanofi says a mixture of external partnerships and mergers are helping shift focus.

Tuesday 20th March 2018

CHO jumping: Samsung BioLogics to develop in-house cell line

Samsung BioLogics will begin offering its own CHO cell line for its customersâ development projects from 2019.

Mundipharma goes up against MSD with Herceptin biosimilar in Europe

Mundipharma says it is not concerned at arriving second to market with a trastuzumab biosimilar after inking a deal to commercialise Celltrionâs Herzuma in seven European countries.

LenioBio teams with Dow for tobacco-based expression system

LenioBio will offer cell-free protein expression (CFPE) kits for drug screening through a partnership with DowDuPont, and says it is looking into using the tech for bioprocessing.

Friday 16th March 2018

ABL Europe equips viral vector plant with Sartorius single-use tech

Both upstream and downstream systems provided by Sartorius Stedim Biotech have been installed in ABLâs facility in Strasbourg, France.

Flexible friend: Sanofi talks capacity benefits of Lonza JV

Sharing a facility with a CMO gives Sanofi the flexibility to adjust biomanufacturing capacity according to its needs, says its SVP for biologics.

Pfenex hunting partners to advance Lucentis and Neulasta biosimilar candidates

Pfenex says it is actively looking for partners for its Lucentis and Neulasta biosimilar programmes, which are presently on hold.

Thursday 15th March 2018

Up to down: BIA and Nuvonis to address ‘last frontier in bioprocessing’

BIA Separations has teamed with Nuvonis Technologies to help vaccine and cell therapy developers tackle the transition from upstream to downstream processing.

Novavax: Flu vaccine failings due to 'outdated' egg-based manufacturing

Egg adaptation is the biggest culprit in this yearâs poor flu vaccine efficacy says Novavax, a firm developing a product based on recombinant protein nanoparticles.

Compugen licenses Selexis cell line tech

Compugen has selected Selexisâ SUREtechnology cell expression platform to generate high-performance research cell banks (RCBs) and support its antibody pipeline.

Tuesday 13th March 2018

iBio: Plants, not cell lines, for next-generation antibodies

iBio has expanded its offering to develop and manufacture Fc fusion therapeutics using it plant-based expression system.

Fujifilm to make AAVs for Regenxbio gene therapies

Regenxbio says a manufacturing contract with Fujifilm Diosynth Biotechnologies will support its gene therapy candidates.

WuXi BioLogics wins Adagene antibody therapeutics contract

WuXi BioLogics will develop and manufacture Adageneâs antibody therapeutics for the Chinese market before expanding globally.

Friday 9th March 2018

Berkeley Lights and MD Anderson launch cell therapy JV

Berkeley Lights and MD Anderson Cancer Centre have created a company aimed at developing autologous cell therapies to treat solid tumours.

First Herceptin biosimilar launched in UK

Merck & Co. will take on Roche as Ontruzant becomes the first biosimilar of cancer drug Herceptin (trastuzumab) to be launched in Europe.

Wednesday 7th March 2018

Cryoport ups cold chain presence on regenerative med potential

Cryoport will open two global centres and has inked a deal with McKesson to support the growth in demand for cell and gene therapy logistics.

Beyond mammalian culture: ABEC’s single-use range to cover microbial fermentation

Bioprocessing vendor ABEC has added microbial fermentation capabilities to its single-use line.

Tuesday 6th March 2018

Irish government develops national policy to drive biosimilar use

Irelandâs National Biosimilar Medicines Policy aims to increase biosimilar use and âdrive downâ the cost of medicines, says government representative.

Scientists look to gene-inserting tech for T-cell modification

A gene-inserting technology that effectively implants large molecules into cells could help modify T-cells from a patientâs immune system, says researcher.

Friday 2nd March 2018

Draper touts new bioprocessing method as ‘next big advance in CAR T-cell treatment’

Draper has designed a microfluidic transduction device (MTD) it claims will help CAR T-cell therapy developers lower costs, up efficiency â and potentially bring manufacturing to the patientâs bedside.

Quick Search


News Quicklinks